Kyle Mikson
Stock Analyst at Canaccord Genuity
(2.15)
# 2,900
Out of 5,147 analysts
124
Total ratings
38.95%
Success rate
-2.75%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $125 → $135 | $93.90 | +43.77% | 11 | Feb 20, 2026 | |
| GRAL GRAIL | Maintains: Buy | $105 → $80 | $53.23 | +50.29% | 6 | Feb 20, 2026 | |
| BDSX Biodesix | Maintains: Buy | $20 | $15.33 | +30.46% | 6 | Feb 17, 2026 | |
| ILMN Illumina | Maintains: Hold | $130 → $150 | $134.46 | +11.56% | 15 | Jan 26, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $79.71 | +113.27% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $23.05 | -13.23% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $53.25 | +50.23% | 3 | Dec 22, 2025 | |
| QTRX Quanterix | Maintains: Hold | $5 → $8 | $6.55 | +22.14% | 8 | Dec 22, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $2 → $1.5 | $0.96 | +56.84% | 6 | Dec 22, 2025 | |
| NTRA Natera | Maintains: Buy | $250 → $285 | $208.04 | +36.99% | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $50 | $29.57 | +69.09% | 6 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $20.14 | +48.96% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $103.38 | +1.57% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $36.59 | +17.52% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $128.73 | +28.18% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $3.62 | +314.36% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.68 | +78.57% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.44 | +108.33% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.21 | +838.97% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,476 | $10.08 | +14,542.86% | 1 | Mar 30, 2021 |
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $125 → $135
Current: $93.90
Upside: +43.77%
GRAIL
Feb 20, 2026
Maintains: Buy
Price Target: $105 → $80
Current: $53.23
Upside: +50.29%
Biodesix
Feb 17, 2026
Maintains: Buy
Price Target: $20
Current: $15.33
Upside: +30.46%
Illumina
Jan 26, 2026
Maintains: Hold
Price Target: $130 → $150
Current: $134.46
Upside: +11.56%
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $79.71
Upside: +113.27%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $23.05
Upside: -13.23%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $53.25
Upside: +50.23%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $6.55
Upside: +22.14%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2 → $1.5
Current: $0.96
Upside: +56.84%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $208.04
Upside: +36.99%
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $29.57
Upside: +69.09%
Dec 22, 2025
Maintains: Hold
Price Target: $28 → $30
Current: $20.14
Upside: +48.96%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $103.38
Upside: +1.57%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $36.59
Upside: +17.52%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $128.73
Upside: +28.18%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $3.62
Upside: +314.36%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.68
Upside: +78.57%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.44
Upside: +108.33%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.21
Upside: +838.97%
Mar 30, 2021
Initiates: Overweight
Price Target: $1,476
Current: $10.08
Upside: +14,542.86%